Bellecapital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Bellecapital's EW Position: Q1 2025 in Review
Bellecapital sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 3,439 shares — an estimated $255K sold.
Bellecapital first reported a position in EW in Q2 2019 and held it in 23 quarters. The position peaked at $857K in Q4 2021. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- Bellecapital reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
- Bellecapital sold 3,439 Edwards Lifesciences shares in Q1 2025, an estimated $255K.
- Bellecapital first reported a position in Edwards Lifesciences in Q2 2019 and held it in 23 quarters.
- Bellecapital's Edwards Lifesciences position peaked at $857K in Q4 2021.
- 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on Bellecapital's 13F filing for Q1 2025, filed 16 Apr 2025.